HP
ALKS icon

HealthInvest Partners’s Alkermes ALKS Stock Holding History

HealthInvest Partners’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
213,329
-29,144
-12% -$1.14M 3.01% 11
2026
Q1 		$8.24M Hold
242,473
– – 2.66% 18
2025
Q4 		$6.78M Sell
242,473
-10,402
-4% -$312K 2.16% 21
2025
Q3 		$7.59M Buy
252,875
+25,651
+11% +$723K 2.99% 13
2025
Q2 		$6.5M Buy
227,224
+12,446
+6% +$370K 2.78% 14
2025
Q1 		$7.09M Sell
214,778
-51,721
-19% -$1.69M 3.13% 14
2024
Q4 		$7.67M Buy
266,499
+29,889
+13% +$859K 3.64% 9
2024
Q3 		$6.62M Buy
236,610
+167,810
+244% +$4.47M 3.11% 13
2024
Q2 		$1.66M Buy
+68,800
New +$1.69M 1.01% 24

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

HealthInvest Partners's ALKS Position: Q2 2026 in Review

HealthInvest Partners reduced its Alkermes (ALKS) stake by 12% in Q2 2026, selling an estimated $1.14M and leaving 213,329 shares worth $11.2M. The position accounts for 3.01% of the portfolio, ranked #11.

HealthInvest Partners first reported a position in ALKS in Q2 2024 and has held it in 9 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • HealthInvest Partners held 213,329 shares of Alkermes worth $11.2M as of Q2 2026.
  • HealthInvest Partners sold 29,144 Alkermes shares in Q2 2026, an estimated $1.14M.
  • Alkermes made up 3.01% of HealthInvest Partners's portfolio in Q2 2026, its #11 holding.
  • HealthInvest Partners first reported a position in Alkermes in Q2 2024 and has held it in 9 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.